CytoMed Therapeutics Limited (GDTC) Capital expenditures 2022–2025
CytoMed Therapeutics Limited (GDTC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$496,034FY2025 · since FY2022: $353,473 → $496,034
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $496,034 | -51.6% |
| FY2024 | $1.0M | +2219.5% |
| FY2023 | $44,186 | -87.5% |
| FY2022 | $353,473 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice